Company news

ImmuCell Corporation news in 2023

ImmuCell Corporation's news releases, calls and decks from 2023, newest first.

View company

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

November 12, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023

November 6, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023

October 4, 2023

ImmuCell Announces Submission of CMC Technical Section to the FDA

August 28, 2023

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023

August 9, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023

August 6, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023

July 10, 2023

ImmuCell Announces Change in Timing of Anticipated FDA Submission

June 27, 2023

ImmuCell Appoints Bryan K. Gathagan to Board of Directors

June 20, 2023

ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility

June 14, 2023

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023

May 10, 2023

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023

May 3, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023

April 4, 2023

ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022

February 20, 2023

ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022

February 14, 2023

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022

January 8, 2023

Calls in 2023

Decks in 2023